Characteristics of clients with schizophrenia who express certainty or uncertainty about continuing treatment with depot neuroleptic medication von Helen Bunn, M., O'Connor, Annette M., Tansey, Margaret Sutherland, Jones, Barry Douglas Walter, Stinson, Linda E.

Volltext

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial von Coles, Alasdair J, Dr, Twyman, Cary L, MD, Arnold, Douglas L, Prof, Cohen, Jeffrey A, Prof, Confavreux, Christian, Prof, Fox, Edward J, MD, Hartung, Hans-Peter, Prof, Havrdova, Eva, Prof, Selmaj, Krzysztof W, Prof, Weiner, Howard L, Prof, Miller, Tamara, MD, Fisher, Elizabeth, PhD, Sandbrink, Rupert, MD, Lake, Stephen L, ScD, Margolin, David H, MD, Oyuela, Pedro, MD, Panzara, Michael A, MD, Compston, D Alastair S, Prof

Volltext

Notes von Ockenden, D. W., Schofield, K., Freund, Walter, Komzak, Alfred, Faseeh, S. A., Callomon, H. J., Thompson, H. W., Andersen, F. Allan, Bak, B rge, Rivett, D. E. A., Potts, K. T., Davison, W. H. T., Sharpe, A. G., Whipple, Richard O., West, Robert, Emerson, Kenneth, Mackie, Alexander, Cutler, A. Anthony, Ingram, V. M., Lloyd, Douglas, Rowe, Frederick, Jones, E. R. H., Bu'Lock, J. D., Landauer, Phyllis D., Rydon, H. N., Owen, L. N., Whitelaw, S. P., Barry, Vincent C., Mitchell, P. W. D., Cowell, D. B., Linnell, W. H., Mathieson, D. W., Baddeley, G., Pickles, W.

Volltext